Prostate cancer aggressiveness: in vivo assessment of MR spectroscopy and diffusion-weighted imaging at 3 T
- PMID: 22843767
- DOI: 10.1148/radiol.12111744
Prostate cancer aggressiveness: in vivo assessment of MR spectroscopy and diffusion-weighted imaging at 3 T
Abstract
Purpose: To determine the individual and combined performance of magnetic resonance (MR) spectroscopic imaging and diffusion-weighted (DW) imaging at 3 T in the in vivo assessment of prostate cancer aggressiveness by using histopathologically defined regions of interest on radical prostatectomy specimens to define the prostate cancer regions to be investigated.
Materials and methods: The local institutional ethics review board approved this retrospective study and waived the informed consent requirement. Fifty-four patients with biopsy-proved prostate cancer underwent clinical MR spectroscopic imaging followed by prostatectomy. Guided by the histopathologic map, all spectroscopy voxels that contained tumor tissue were selected, and metabolite ratios (choline [Cho] plus creatine [Cr]-to-citrate [Cit] and Cho/Cr ratios) were derived. For each spectroscopic voxel, 25th percentile apparent diffusion coefficient (ADC) of the region corresponding to that voxel was determined, representing the most aberrant tumor part on the ADC map, which was often smaller than spectroscopic imaging voxels. Maximum metabolic ratios and minimum 25th percentile ADC of each tumor were related to tumor aggressiveness and were used to differentiate aggressiveness classes. A logistic regression model (LRM) was used to combine data from both modalities.
Results: Significant correlation was found between aggressiveness classes and maximum Cho+Cr/Cit ratio (ρ=0.36), maximum Cho/Cr ratio (ρ=0.35), and minimum 25th percentile ADC (ρ=-0.63) in the peripheral zone (PZ). In the transition zone (TZ), the correlation was significant for only Cho+Cr/Cit and Cho/Cr ratios (ρ=0.58 and ρ=0.60, respectively). For differentiation between aggressiveness classes, LRM use did not result in significantly improved differentiation over any individual variables.
Conclusion: These findings enabled confirmation that MR spectroscopic imaging and DW imaging offer potential for in vivo noninvasive assessment of prostate cancer aggressiveness, and both modalities have comparable performance. The combination did not result in better performance. Nonetheless, the better performances of metabolite ratios in the TZ and of ADCs in the PZ suggest that they have complementary value.
© RSNA, 2012
Similar articles
-
Contribution of Histopathologic Tissue Composition to Quantitative MR Spectroscopy and Diffusion-weighted Imaging of the Prostate.Radiology. 2016 Mar;278(3):801-11. doi: 10.1148/radiol.2015142889. Epub 2015 Sep 29. Radiology. 2016. PMID: 26418614
-
Metabolite ratios in 1H MR spectroscopic imaging of the prostate.Magn Reson Med. 2015 Jan;73(1):1-12. doi: 10.1002/mrm.25122. Epub 2014 Jan 31. Magn Reson Med. 2015. PMID: 24488656 Review.
-
In vivo assessment of prostate cancer aggressiveness using magnetic resonance spectroscopic imaging at 3 T with an endorectal coil.Eur Urol. 2011 Nov;60(5):1074-80. doi: 10.1016/j.eururo.2011.03.002. Epub 2011 Mar 17. Eur Urol. 2011. PMID: 21419565
-
Diffusion-weighted imaging with apparent diffusion coefficient mapping and spectroscopy in prostate cancer.Top Magn Reson Imaging. 2008 Dec;19(6):261-72. doi: 10.1097/RMR.0b013e3181aa6b50. Top Magn Reson Imaging. 2008. PMID: 19512848 Free PMC article. Review.
-
Combined use of diffusion-weighted MRI and 1H MR spectroscopy to increase accuracy in prostate cancer detection.AJR Am J Roentgenol. 2007 Jan;188(1):91-8. doi: 10.2214/AJR.05.2198. AJR Am J Roentgenol. 2007. PMID: 17179350
Cited by
-
Repeatability and reproducibility of prostate apparent diffusion coefficient values on a 1.5 T magnetic resonance linear accelerator.Phys Imaging Radiat Oncol. 2024 Mar 15;30:100570. doi: 10.1016/j.phro.2024.100570. eCollection 2024 Apr. Phys Imaging Radiat Oncol. 2024. PMID: 38544680 Free PMC article.
-
Radiogenomics Reveals Correlation between Quantitative Texture Radiomic Features of Biparametric MRI and Hypoxia-Related Gene Expression in Men with Localised Prostate Cancer.J Clin Med. 2023 Mar 30;12(7):2605. doi: 10.3390/jcm12072605. J Clin Med. 2023. PMID: 37048688 Free PMC article.
-
MRI radiomics predicts progression-free survival in prostate cancer.Front Oncol. 2022 Aug 30;12:974257. doi: 10.3389/fonc.2022.974257. eCollection 2022. Front Oncol. 2022. PMID: 36110963 Free PMC article.
-
Prospective evaluation of PI-RADS v2 and quantitative MRI for clinically significant prostate cancer detection in Indian men - East meets West.Arab J Urol. 2022 May 15;20(3):126-136. doi: 10.1080/2090598X.2022.2072141. eCollection 2022. Arab J Urol. 2022. PMID: 35935908 Free PMC article.
-
Metabolic reprogramming as an emerging mechanism of resistance to endocrine therapies in prostate cancer.Cancer Drug Resist. 2021 Mar 19;4(1):143-162. doi: 10.20517/cdr.2020.54. eCollection 2021. Cancer Drug Resist. 2021. PMID: 35582011 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical